ArticleAdvanced pharmaceutical bulletin2024

Exploring a Synergistic Approach: Dual GLP-1 Agonist Combined with Degludec Basal Insulin for Early Type 1 Diabetes Treatment and its Impact on Albumin-Insulin Producing Cells Expression.

Amr Ahmed et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.